These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4698954)

  • 41. Atypical measles in children previously immunized with attenuated measles virus vaccines.
    Cherry JD; Feigin RD; Lobes LA; Shackelford PG
    Pediatrics; 1972 Nov; 50(5):712-7. PubMed ID: 5084185
    [No Abstract]   [Full Text] [Related]  

  • 42. Measles antibodies in nasal secretions and sera of children with measles.
    Polna I; Aleksandrowicz J; Krawczyński K; Krotochwil-Skrzypek M; Rozskowska K
    Acta Virol; 1977 Jul; 21(4):331-7. PubMed ID: 20768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Several indices of humoral anti-measles immunity in children, previously immunized with live measles vaccine, who have developed measles].
    Tikhonova NT; Khrometskaia TM; Livanova LV; Poliakova TA; Azarova SA
    Vopr Virusol; 1978; (3):322-7. PubMed ID: 695522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An evaluation of measles serodiagnosis during an outbreak in a vaccinated community.
    Sekla L; Stackiw W; Eibisch G; Johnson I
    Clin Invest Med; 1988 Aug; 11(4):304-9. PubMed ID: 3168353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measles vaccine reactions in a virgin population.
    Black FL; Woodall JP; Pinheiro FD
    Am J Epidemiol; 1969 Feb; 89(2):168-75. PubMed ID: 5765956
    [No Abstract]   [Full Text] [Related]  

  • 46. The status of measles after five years of mass vaccination in the USSR.
    Burgasov PN; Andzaparidze OG; Popov VF
    Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antibodies of differing physicochemical nature in antimeasles postvaccinal immunity].
    Tikhonov NT; Khrometskaia TM; Kholchev NV; Nesterova TP
    Vopr Virusol; 1973; 18(4):397-402. PubMed ID: 4786159
    [No Abstract]   [Full Text] [Related]  

  • 48. Measles seroconfirmation using dried capillary blood specimens in filter paper.
    Wassilak SG; Bernier RH; Herrmann KL; Orenstein WA; Bart KJ; Amler R
    Pediatr Infect Dis; 1984; 3(2):117-21. PubMed ID: 6728701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparative evaluation of 3 measles vaccines. 3. Evaluation of the hemagglutination inhibition test for assaying measles antibodies after vaccination].
    Polna I; Naruszewicz-Lesiuk D; Pilecka T
    Przegl Epidemiol; 1970; 24(3):339-47. PubMed ID: 5482214
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunoglobulin response and viremia in dengue-vaccinated gibbons repeatedly challenged with Japanese encephalitis virus.
    Edelman R; Nisalak A; Pariyanonda A; Udomsakdi S; Johnsen DO
    Am J Epidemiol; 1973 Mar; 97(3):208-18. PubMed ID: 4348246
    [No Abstract]   [Full Text] [Related]  

  • 51. Vaccination against measles in the Canadian Arctic.
    Furesz J; Habgood M
    JAMA; 1966 Jan; 195(5):342-4. PubMed ID: 5951890
    [No Abstract]   [Full Text] [Related]  

  • 52. Evaluation of a measles-smallpox vaccination campaign by a sero-epidemiologic method.
    Breman JG; Coffi E; Bomba-Ire R; Foster SO; Herrmann KL
    Am J Epidemiol; 1975 Dec; 102(6):564-71. PubMed ID: 173183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
    Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
    Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
    [No Abstract]   [Full Text] [Related]  

  • 54. Field evaluation of combined more attenuated live measles (Moraten)-smallpox vaccine in Honduras and Costa Rica.
    Villarejos VM; Rodríguez-Aragonés A; Gúnera N; Arguedas JA; Buynak EB; Hilleman MR
    Am J Epidemiol; 1971 May; 93(5):384-91. PubMed ID: 5556398
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunoglobulin classes of serum antibodies formed in response to natural infections with myxo- and pseudomyxoviruses among infants and children.
    Sekiguchi H; Numazaki Y; Yano N; Homma M; Ishida N
    Jpn J Microbiol; 1969 Sep; 13(3):293-301. PubMed ID: 4186663
    [No Abstract]   [Full Text] [Related]  

  • 56. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure.
    Albrecht P; Ennis FA; Saltzman EJ; Krugman S
    J Pediatr; 1977 Nov; 91(5):715-8. PubMed ID: 909009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population.
    Edmonson MB; Addiss DG; McPherson JT; Berg JL; Circo SR; Davis JP
    JAMA; 1990 May; 263(18):2467-71. PubMed ID: 2278542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An evaluation of measles revaccination among school-entry-aged children.
    Watson JC; Pearson JA; Markowitz LE; Baughman AL; Erdman DD; Bellini WJ; Baron RC; Fleming DW
    Pediatrics; 1996 May; 97(5):613-8. PubMed ID: 8628596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A seroepidemiologic study of a measles epidemic in a highly immunized population.
    Linnemann CC; Rotte TC; Schiff GM; Youtsey JL
    Am J Epidemiol; 1972 Mar; 95(3):238-46. PubMed ID: 5010820
    [No Abstract]   [Full Text] [Related]  

  • 60. MEASLES VACCINATION. I. SEROLOGIC RESPONSES TO AN INACTIVATED VACCINE.
    NORRBY E; LAGERCRANTZ R; GARD S; CARLSTROEM G
    Arch Gesamte Virusforsch; 1963 Aug; 13():548-58. PubMed ID: 14085248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.